A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BAL2420 in Healthy Adult Subjects

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BAL2420 in Healthy Adult Subjects	Healthy	Recruiting	Phase 1	2026-09-14		NCT07500181

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Basilea Pharmaceutica	5
German Federal Ministry of Education and Research	30
Health Emergency Preparedness and Response Authority	1
Italian Ministry of Economy and Finance	1
Novo Nordisk Foundation	11
Wellcome Trust 224842/Z/21/Z	2
Wellcome Trust 325026/Z/25/Z	1

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
ICON Early Clinical & Bioanalytical Solutions	Groningen	Netherlands	1

Clinical trials